{
  "id": "802f470a2023ffe2",
  "title": "NCCN Names Trodelvy a Preferred First - Line Treatment for Metastatic TNBC",
  "description": "20260205T004500Z",
  "content": "",
  "source": "curetoday.com",
  "source_url": "https://www.curetoday.com/view/nccn-names-trodelvy-a-preferred-first-line-treatment-for-metastatic-tnbc",
  "published_at": "20260205T004500Z",
  "fetched_at": "2026-02-06T00:27:14.258190+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.curetoday.com/view/nccn-names-trodelvy-a-preferred-first-line-treatment-for-metastatic-tnbc",
    "url_mobile": "",
    "title": "NCCN Names Trodelvy a Preferred First - Line Treatment for Metastatic TNBC",
    "seendate": "20260205T004500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/curetoday/2a05a896d1eac463ccb79b3615296fdb75dc82b4-1280x720.jpg",
    "domain": "curetoday.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}